# Bioreliance Corporation – FDA Inspection, Aug 8, 2019

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7e151514-be3f-4b8f-ba64-e4ad411f7cc0
Source feed: FDA_Inspections

> FDA inspection 1099981 of Bioreliance Corporation, August 08, 2019. Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099981
- Company Name: Bioreliance Corporation
- Inspection Date: 2019-08-08
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Baltimore District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1295306 - 2026-01-29](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/e199758b-3727-437f-82a7-ea444bde9780)
- [FDA Inspection 1254934 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7941bc6b-db19-4266-b05d-af8a19fbde51)
- [FDA Inspection 1215040 - 2023-08-04](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/89149f6b-0201-4f3c-9500-60de669dfba4)
- [FDA Inspection 1059115 - 2018-07-13](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/ba69306a-6c03-404f-b4e3-7b18e0e140f0)
- FDA Inspection 983525 - 2016-01-11

## Related Officers

- [Byungja E. Marciante](https://www.keypedia.com/people/byungja-e-marciante/5d1f2927-9017-4ab6-8ad2-521e340ef14f)
- [Company Rep](https://www.keypedia.com/people/charles-r-bonapace/f1056c3d-2384-48e0-812d-202ca96ae710)
- [Company Rep](https://www.keypedia.com/people/mark-j-seaton/640c2deb-25ff-4e2e-8f48-d15d31f9c5bf)
- [Company Rep](https://www.keypedia.com/people/zhou-chen/03362438-eba1-4010-b6b1-5cccf25a824c)

Company: https://www.keypedia.com/companies/bioreliance-corporation/08d3dc20-6c7e-4f04-bb98-bbc868e70000

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa